Overview Request Sample Pages Request Customization Download PDF
You are viewing: Mexico Proteomics Market analysis
Part of: Proteomics Market (Global)

The Mexico Proteomics Market was valued at $145.4 Million in 2026 and projected to reach to $210.9 Million by 2031, representing a compound annual growth rate of 7.7%. Mexico's proteomics market is experiencing steady expansion driven by enhanced healthcare infrastructure investments and growing recognition of protein-based diagnostics in clinical practice.

Mexico Proteomics Market Trends and Insights

  • Valued at $145.4 million in 2026, Mexico's proteomics market is expected to expand to $210.9 million by 2031, reflecting a compound annual growth rate of 7.7%.
  • This growth trajectory in Mexico is driven by increasing healthcare investments, rising adoption of advanced diagnostic technologies, and expanding pharmaceutical research capabilities across the country. The proteomics sector in Mexico benefits from strengthening institutional research infrastructure and growing demand for personalized medicine solutions.
  • Mexico's market expansion is supported by collaborations between academic institutions and private sector players, alongside government initiatives to modernize healthcare diagnostics.
  • By 2031, Mexico is anticipated to capture a more significant share of proteomics applications in clinical diagnostics, drug discovery, and biomarker development. Mexico's proteomics market reflects broader Latin American trends toward precision medicine adoption, though Mexico's growth rate of 7.7% remains measured compared to global expansion rates.
  • The country's strategic position in North America and its developing biopharmaceutical sector position Mexico as an emerging hub for proteomics innovation and clinical implementation..

Key Market Statistics

  • CAGR (2026-2031) 7.7% CAGR
  • Market Size, 2026 ~USD 145.4 Million
  • Forecast, 2031 ~USD 210.9 Million
  • Country Mexico

Mexico Proteomics Market Overview

Market Valuation Growth :

Mexico's proteomics market is valued at $145.4 million in 2026 and is projected to reach $210.9 million by 2031, representing a 45.1% increase over the five-year forecast period.

CAGR Performance :

Mexico's proteomics market is expanding at a 7.7% CAGR from 2026 to 2031, outpacing several regional markets while remaining below the global average of 11.1%, indicating steady but moderate growth potential.

Healthcare Investment Drivers :

Increasing government and private healthcare investments in Mexico are fueling adoption of advanced diagnostic technologies and proteomics-based solutions across clinical and research institutions.

Latin American Position :

Mexico represents a significant growth segment within Latin America's life sciences ecosystem, positioning itself as a key market for proteomics innovation and clinical application expansion in the region.

Mexico Proteomics Market Dynamics

  • The market's 7.7% CAGR reflects increasing adoption among hospitals, diagnostic laboratories, and research institutions seeking advanced analytical capabilities.
  • Rising prevalence of chronic diseases and improved access to sophisticated diagnostic tools are accelerating market penetration across major metropolitan areas. Looking ahead to 2031, Mexico's proteomics sector is poised for continued growth as healthcare providers prioritize precision medicine initiatives and personalized treatment approaches.
  • Collaborations between Mexican research institutions and international biotech firms, combined with regulatory support for advanced diagnostics, will further strengthen market dynamics.
  • The transition from traditional diagnostic methods to proteomics-enabled solutions presents substantial opportunities for market participants targeting Mexico's evolving healthcare landscape..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Mexico's proteomics market is valued at $145.4 million in 2026 and is projected to reach $210.9 million by 2031, growing at a 7.7% CAGR.
      • Mexico's market growth is driven by increased healthcare investments, adoption of advanced diagnostic technologies, and expanding pharmaceutical research infrastructure.
      • Mexico's proteomics sector is supported by academic-industry collaborations and government initiatives to modernize healthcare diagnostics and precision medicine.
      • Mexico's growth rate of 7.7% reflects steady but measured expansion compared to global proteomics market growth, positioning the country as an emerging Latin American hub.

      Proteomics Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment ANTIBODIES & HIGH-AFFINITY BINDERS (Type)
      Forecast Period 2026–2031
      Growth Rate CAGR of 11.1% from 2026 to 2031
      Largest Segment REAGENTS & CONSUMABLES (Offering)
      Market Size Base Year (Billions) ~USD 39.91 (2026)
      Revenue Forecast (Billions) ~USD 67.55 (2031)
      Segments Covered Offering, Reagents & Consumables, Type, Instrumentation Technology

      Mexico Proteomics Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Offering

      • Instruments
      • Reagents & Consumables
      • Services
      • Software

      By Reagents & Consumables

      • Chromatography Reagents & Consumables
      • Electrophoresis Reagents & Consumables
      • Immunoassay Reagents & Consumables
      • Other Reagents & Consumables
      • Protein Fractionation Reagents & Consumables
      • Protein Microarray Reagents & Consumables
      • Spectroscopy Reagents & Consumables
      • X-Ray Crystallography Reagents & Consumables

      By Type

      • Analytical Columns
      • Antibodies & High-Affinity Binders
      • Assay Kits
      • Biochips
      • Cd Spectroscopy
      • Crystallization Screens
      • Detection Reagents
      • Electrophoresis Stains & Dyes
      • Enzymes
      • Lab-On-Chips
      • Mass Spectrometry
      • Mass Tagging & Labeling Kits
      • Nmr Spectroscopy
      • Other Chromatography Reagents & Consumables
      • Other Electrophoresis Reagents & Consumables
      • Other Immunoassay Reagents & Consumables
      • Other Protein Fractionation Reagents & Consumables
      • Other Spectroscopy Reagents & Consumables
      • Other X-Ray Crystallography Reagents & Consumables
      • Protein Chips
      • Protein Fractionation & Enrichment Kits
      • Reagents

      By Instrumentation Technology

      • Chromatography
      • Electrophoresis
      • Other Instrumentation Technologies
      • Protein Fractionation
      • Protein Microarrays
      • Spectroscopy
      • Surface Plasmon Resonance
      • X-Ray Crystallography

      Target Audience

      • Proteomics Equipment Manufacturers : Manufacturers need Mexico-specific market data to assess demand for mass spectrometry, protein analysis instruments, and diagnostic platforms, and to develop localized sales and distribution strategies.
      • Diagnostic Laboratory Operators : Laboratory operators require market insights to evaluate investment opportunities in proteomics capabilities, understand competitive positioning, and plan service expansion across Mexico's healthcare facilities.
      • Healthcare Investment Firms : Investment professionals need detailed Mexico market analysis to identify high-growth opportunities in proteomics companies, diagnostic service providers, and healthcare technology ventures in the region.
      • Pharmaceutical & Biotech Companies : Pharma and biotech firms need Mexico market intelligence to support precision medicine initiatives, companion diagnostic development, and clinical trial planning in this growing Latin American market.
      • Healthcare Policy & Regulatory Bodies : Government agencies and regulatory organizations require market data to inform healthcare policy decisions, diagnostic technology adoption initiatives, and precision medicine framework development in Mexico.

      Key Companies in the Mexico Proteomics Market

      CompanyHQOwnershipStrongest segments
      ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics systems (chemistry, hematology, immunoassay, urinalysis, blood banking, hemostasis),Research and discovery instruments (flow cytometry, centrifugation, capillary electrophoresis, genomics, liquid handling, automation),Industrial and particle characterization systems,
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (pMDIs, DPIs) and components,Autoinjectors and injectable delivery systems,Nasal and other specialty drug delivery devices,
      TOSOH CORPORATIONJapanPublic CompanyBasic chemicals & chlor-alkali (caustic soda, VCM, sodium bicarbonate, related),Petrochemicals & polymers (ethylene, propylene, PE, EVA, synthetic rubber, functional polymers),Advanced materials (battery materials, quartzware, silica glass, thin films, zeolites, zirconia, fine beads),
      CODEXIS, INC.United StatesPublic CompanyCodeEvolver-enabled enzymes for therapeutics manufacturing,ECO Synthesis platform for RNAi and nucleic acid manufacturing,Licensing and technology access agreements,
      MAXCYTE, INCUnited StatesPublic CompanyExPERT instruments (ATx, STx, GTx, VLx),Processing assemblies and consumables,Licensing and technology access,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      AGILENT T ECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      MERCK KGAAGermanyPublic CompanyLife Science (tools, reagents, bioprocessing, CDMO services),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment),
      DANAHER C O RPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (instruments, genomics, and lab automation),Diagnostics (clinical instruments and consumables),
      SHIM A DZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery,
      WATER S CORPORATIONUnited StatesPublic CompanyLiquid Chromatography Systems and Columns,Mass Spectrometry Systems,TA Instruments (Thermal Analysis, Rheometry, Calorimetry),
      BIO-RAD LABOR A TORIES, INC.United StatesPublic CompanyClinical Diagnostics systems, kits, and quality controls,Life Science instruments and reagents,Software, informatics, and other,
      BRUKERUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry and diagnostics),BSI Nano (X-ray, AFM, EM analytics, optical microscopy),
      REVVITYUnited StatesPublic CompanyClinical diagnostics (prenatal, newborn, infectious disease, autoimmune),Life science reagents and assays (BioLegend, Dharmacon, AlphaLISA, etc.),Instruments and imaging systems,
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep, WGS and targeted kits),Arrays and genotyping solutions,
      EUROF I NS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing,Environment Testing,Biopharma Testing and Services,
      QIAG E NNetherlandsPublic CompanySample technology consumables and instruments,PCR and digital PCR (consumables and instruments),Immune response and infectious disease assays (incl. TB),
      CHARLES R IVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 that employs 1,760 people. The company operates in the life sciences sector.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees. The company operates in the diagnostics and laboratory equipment industry.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company operates in the medical devices and healthcare sector.

      TOSOH CORPORATION

      Tosoh Corporation is a Japan-based public company founded in 1935 with 14,850 employees. The company operates across multiple sectors including specialty chemicals and diagnostics.

      CODEXIS, INC.

      Codexis, Inc. is a United States-based public company founded in 2002 with 146 employees. The company specializes in enzyme engineering and biocatalysis technologies.

      MAXCYTE, INC

      MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees. The company develops cell engineering technologies and solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, analytical instruments, and laboratory services.

      AGILENT T ECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials sectors.

      DANAHER C O RPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates across diagnostics, life sciences, environmental and applied solutions.

      SHIM A DZU CORPORATION

      Shimadzu Corporation is a Japan-based public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

      WATER S CORPORATION

      Waters Corporation is a United States-based public company founded in 1958 with 7,900 employees. The company develops and manufactures analytical instruments and software for laboratory analysis.

      BIO-RAD LABOR A TORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

      BRUKER

      Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops and manufactures scientific instruments for molecular and materials research.

      REVVITY

      Revvity is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company is a leader in DNA sequencing and genetic analysis technologies.

      EUROF I NS SCIENTIFIC

      Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company provides laboratory testing services across pharmaceutical, food, environmental, and clinical sectors.

      QIAG E N

      Qiagen is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and sample preparation technologies.

      CHARLES R IVER LABORATORIES

      Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development and safety testing.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for Mexico's proteomics market ($145.4M in 2026) with detailed five-year forecasts to support investment decisions and business planning in this emerging Latin American market.
      • Competitive Landscape Intelligence : Understand Mexico-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies tailored to the Mexican healthcare ecosystem.
      • Regional Growth Benchmarking : Compare Mexico's 7.7% CAGR against global (11.1%) and regional benchmarks to assess relative market attractiveness and prioritize resource allocation across Latin American markets.
      • Healthcare Investment Trends : Access insights into Mexico's increasing healthcare investments and adoption of advanced diagnostic technologies to identify emerging opportunities in clinical laboratories, hospitals, and research institutions.
      • Strategic Market Positioning : Leverage Mexico-specific data to develop targeted go-to-market strategies, pricing models, and product positioning that align with local healthcare regulations, infrastructure, and customer preferences.

      Frequently asked questions

      What is the current size of Mexico's proteomics market?

      Mexico's proteomics market is estimated at $145.4 million in 2026 and is expected to grow to $210.9 million by 2031.

      What is the projected growth rate for Mexico's proteomics market?

      Mexico's proteomics market is projected to grow at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2031.

      What factors are driving growth in Mexico's proteomics market?

      Mexico's proteomics market growth is driven by increased healthcare investments, rising adoption of advanced diagnostic technologies, expanding pharmaceutical research capabilities, and government initiatives to modernize healthcare diagnostics.

      How does Mexico's proteomics market compare to the global market?

      Mexico's proteomics market is growing at 7.7% CAGR, which is lower than the global proteomics market CAGR of 11.1%, reflecting Mexico's position as an emerging market within Latin America.

      What applications are driving proteomics adoption in Mexico?

      Mexico's proteomics market is being driven by applications in clinical diagnostics, drug discovery, biomarker development, and personalized medicine solutions across academic and private sector institutions.

      RESEARCH METHODOLOGY

      This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global proteomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.

      Secondary Research

      Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the proteomics market. The secondary sources used for this study include Centre for Drug Evaluation and Research, European Proteomics Association (EuPA), European Medicines Agency (EMA), European Bioinformatics Institute (EMBL-EBI), French Society for Electrophoresis and Proteomics Analysis (SFEAP), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), United Kingdom’s Research and Innovation’s (UKRI), World Journal of Pharmaceutical Sciences (WJPS), National Institutes of Health, and National Center for Biotechnology Information (NCBI).  Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations, among others. Secondary data were collected and analyzed to determine the overall size of the global proteomics market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      Proteomics Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the proteomics market. These methods were also used extensively to estimate the size of various market segments.

      Proteomics Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

      Market Definition

      Proteomics involves the comprehensive evaluation of the structure and function of proteins to understand an organism's nature. It systematically identifies and characterizes proteins, including their sequences, abundances, post-translational modifications, interactions, activities, subcellular localizations, and structures.

      Key Stakeholders

      • Pharmaceutical & biotechnology companies
      • Contract research organizations (CROs)
      • Life science companies
      • Academic & research institutes
      • Private research institutes
      • Venture capitalists & investors
      • Clinical laboratories and diagnostic laboratories
      • Biobanks and translational research centers
      • Market research & consulting firms
      • Government associations
      • Medical institutions & universities
      • Hospitals & clinics

      Report Objectives

      • To define, describe, and forecast the proteomics market based on offering, instrumentation technology, reagents & consumables, type, service, software, workflow, application, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall proteomics market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the proteomics market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the proteomics market
      • To benchmark players within the proteomics market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Geographical Analysis

      • Further breakdown of the Rest of Europe Proteomics Market, by country
      • Further breakdown of the Rest of Asia Pacific Proteomics Market, by country
      • Further breakdown of the Rest of Latin America Proteomics Market, by country
      • Further breakdown of the Rest of Middle East Proteomics Market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

       

      Get the Full Proteomics Market Report

      Full forecast, segment splits, and company analysis for all Proteomics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status